JusticeItaly Official institution

Italy authorizes Beotebal, a biotin-based medicine

Italy's medicines regulator, the Agenzia Italiana del Farmaco (AIFA), published a notice on 7 November 2026 announcing marketing authorization for Beotebal, a human medicine based on biotin. Marketing authorization means the product is cleared to be sold in Italy. The excerpt provided does not give further details such as dosage, indications, or license holder.

This summary was generated by AI; the official source prevails.

What does it mean?

Italy's medicines regulator has officially cleared a new medicine called Beotebal for sale in Italy. The notice itself does not say more about what it is used for or how it is sold.